Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study

Jing Zhang(Sichuan University), Peiming Ma(GlaxoSmithKline (China)), Cui Xiong(GlaxoSmithKline (China)), Jian Wu(Soochow University), Chao Li(Eli Lilly (United States)), Yinghua Shen(GlaxoSmithKline (China)), Yu Xue(First Hospital of China Medical University), Weiguo Wan(Fudan University), Jun Dong, Guoying Cao(Fudan University), Liyan Miao(Soochow University)
Rheumatology and Therapy
January 17, 2020
Cited by 7


Related Papers